Evidence map›Paper›PMID 37237640›Full record

ArticleBioengineering (Basel, Switzerland)2023

Assessment of the Influence of 5-Fluorouracil on SMAD4 and TGFB1 Gene Expression, Apoptosis Induction and DNA Damage in Human Cell Lines.

Agnieszka Wosiak, Dagmara Szmajda-Krygier, Jacek Pietrzak, Joanna Boncela, Ewa Balcerczak

Open access · goldAbstract read
In one paragraph

Article in Bioengineering (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Anti-Inflammatory and Antioxidant Effects of (6International journal of molecular sciences · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Agnieszka WosiakLaboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 1 Muszynskiego, 90-151 Lodz, Poland.ORCID 0000-0002-1732-0233
Dagmara Szmajda-KrygierLaboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 1 Muszynskiego, 90-151 Lodz, Poland.ORCID 0000-0002-9524-6032
Jacek PietrzakLaboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 1 Muszynskiego, 90-151 Lodz, Poland.ORCID 0000-0002-9187-1199
Joanna BoncelaInstitute of Medical Biology, Polish Academy of Science, 106 Lodowa, 93-232 Lodz, Poland.ORCID 0000-0001-8419-7012
Ewa BalcerczakLaboratory of Molecular Diagnostics and Pharmacogenomics, Department of Pharmaceutical Biochemistry and Molecular Diagnostics, Medical University of Lodz, 1 Muszynskiego, 90-151 Lodz, Poland.ORCID 0000-0001-5257-2914
Medical University of Lodz · PLInstitute for Medical Biology · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeSuppressor of mothers against decapentaplegic homolog 4 (SMAD family member 4, PATIENTS AND

methodsThe effect of 5-FU on the expression of

resultsSignificant changes in the level of

conclusionThe observed in vitro changes in CACO-2 cells caused by 5-FU may be of clinical relevance when choosing the drug concentration for treating patients with colorectal cancer. It is possible that 5-FU has a stronger effect on colorectal cancer cells at the higher concentrations. Low concentrations of 5-FU may not have a therapeutic effect and may also influence drug resistance in cancer cells. Higher concentrations and prolonged exposure time may affect

Indexed as

5-fluorouracilCACO-2cell linecolorectal cancerSMAD4SW480SW620TGFB1

Identifiers

PMID37237640
PMCPMC10215742
OpenAlexW4376115505

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.